The Macular Degeneration Stem Cell Treatment Consists of the Following:
10 Million Stem Cells via Injection through the lower eyelid and below the eyeball
Each eye gets 10 million MSCs so it is 2 shots total
PRICE: $2,500 USD
- Day 1 – Arrive and rest
- Day 2 – Bloodwork & Payment
- Day 3 – Treatment
- Day 4 – Rest Day
- Day 5 – Fly home
The Macular Degeneration Stem Cell Treatment for Eye Health
Unlock a Brighter Future with DreamBody Clinic’s Stem Cell Treatment for Macular Degeneration
Are you or a loved one struggling with vision loss due to macular degeneration? DreamBody Clinic offers a groundbreaking solution that could change your life. Our advanced stem cell treatment is designed to combat the effects of macular degeneration, giving you hope for a clearer, brighter future.
Why Choose DreamBody Clinic?
1. Cutting-Edge Stem Cell Therapy: At Dream Body Clinic, we utilize the latest advancements in mesenchymal stem cell (MSC) therapy to target and repair the damage caused by macular degeneration. Our treatment harnesses the power of MSCs to promote retinal cell regeneration and reduce inflammation, offering a potential breakthrough in preserving and restoring vision. Most patients see peak results between 3 to 6 months post treatment, but results can come even sooner.
2. Expertise and Experience: Our team of highly trained medical professionals is dedicated to providing top-notch care. With years of experience in stem cell therapies, we ensure that you receive the best possible treatment tailored to your specific needs.
3. Comprehensive and Personalized Care: We understand that each patient’s journey with macular degeneration is unique. That’s why we offer personalized treatment plans, designed to address your individual condition and maximize the potential benefits of stem cell therapy.
4. Safe and Regulated Procedures: Patient safety is our top priority. All our procedures are conducted in a state-of-the-art facility, adhering to the highest medical standards and regulatory guidelines. We ensure that you receive safe, effective, and reliable treatment.
5. Positive Outcomes and Patient Satisfaction: Our patients have reported significant improvements in their vision and quality of life. We pride ourselves on the positive feedback and success stories from those who have undergone our stem cell treatment for macular degeneration.
Our stem cell therapy involves a minimally invasive procedure where mesenchymal stem cells are administered to the affected areas of the eye.
What to Expect
From your first consultation to post-treatment follow-ups, our team will guide you every step of the way. We provide detailed information about the procedure, expected outcomes, and aftercare to ensure you are fully informed and comfortable throughout the process.
Take the First Step Towards Better Vision
Don’t let macular degeneration control your life. Take charge of your vision health with Dream Body Clinic’s innovative stem cell treatment.
Experience the future of vision care at Dream Body Clinic, where cutting-edge science meets compassionate care. Your journey to clearer vision starts here.
Call (307) 461-5393 For a Free Consultation
How can Mesenchymal Stem Cells Help Treat Macular Degeneration?
Mesenchymal stem cells (MSCs) help in treating macular degeneration through several mechanisms:
Paracrine Signaling: MSCs secrete a variety of growth factors, cytokines, and other molecules that can promote cell survival, reduce inflammation, and inhibit angiogenesis (formation of new blood vessels). These factors can help protect and repair damaged retinal cells in macular degeneration.
Immunomodulation: MSCs can modulate the immune response, suppressing inflammation and promoting tissue repair. This immunomodulatory effect can help reduce the damage caused by chronic inflammation, a key contributor to macular degeneration progression.
Differentiation Potential: MSCs can’t differentiate into retinal cells, but they can still contribute to tissue regeneration by guiding other cells to differentiate into other cell types that support retinal function, such as retinal pigment epithelial cells or vascular endothelial cells.
Mitochondrial Transfer: MSCs have been shown to transfer healthy mitochondria (the energy-producing organelles of cells) to damaged retinal cells, potentially rescuing their function and delaying degeneration.
Exosome Release: MSCs secrete exosomes, small vesicles that carry proteins, lipids, and genetic material. These exosomes can also exert protective and regenerative effects on retinal cells.
It is very difficult to study the exact methods by which MSCs help heal macular degeneration, but results have spoken volumes about their effectiveness.
Stem Cells Can help with Wet AMD and Dry AMD
Mesenchymal stem cells (MSCs) have the potential to help in the treatment of wet age-related macular degeneration (AMD) and dry age-related macular degeneration through several mechanisms.
Wet AMD is characterized by abnormal blood vessel growth (neovascularization) under the retina, leading to leakage, bleeding, and scarring, which ultimately result in vision loss. Here’s how MSCs can assist in treating wet AMD:
Mechanisms of Action:
Anti-Inflammatory Effects:
- Immune Modulation: MSCs can modulate the immune response, reducing inflammation that exacerbates wet AMD. They secrete anti-inflammatory cytokines that help in controlling local inflammation in the retina.
- Cytokine Secretion: By secreting anti-inflammatory cytokines like IL-10 and TGF-β, MSCs help reduce the inflammation that can damage retinal tissues.
Regulation of Angiogenesis:
- Inhibition of Abnormal Blood Vessel Growth: MSCs can secrete factors that inhibit the formation of abnormal blood vessels, which is a hallmark of wet AMD. They help in balancing pro-angiogenic and anti-angiogenic factors.
- Promotion of Normal Vascularization: While inhibiting pathological neovascularization, MSCs can promote the formation of normal blood vessels, helping to maintain retinal health.
Secretion of Trophic Factors:
- Neurotrophic Support: MSCs secrete neurotrophic factors such as brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF), which support the survival and function of retinal cells.
- Retinal Pigment Epithelium (RPE) Protection: These factors help in protecting and repairing the retinal pigment epithelium, which is crucial for retinal health and function.
Paracrine Effects:
- Growth Factors: MSCs release growth factors like vascular endothelial growth factor (VEGF) in a controlled manner, which can help in stabilizing and repairing blood vessels without promoting excessive neovascularization.
- Extracellular Vesicles: MSCs release exosomes and microvesicles that carry proteins, lipids, and RNAs, which can promote tissue repair and modulate the local cellular environment.
Cell Replacement and Repair:
- Tissue Regeneration: Although the primary mechanism of MSCs is through paracrine signaling, the MSCs can guide other cells to differentiate into retinal cells or support endogenous repair mechanisms, contributing to the regeneration of damaged tissues.
Macular Degeneration Stem Cell Treatment Studies
A Review on Mesenchymal Stem Cells for Treatment of Retinal Diseases
Cellular Reparative Mechanisms of Mesenchymal Stem Cells for Retinal Diseases
Mesenchymal stem cell exosomes as nanotherapeutics for dry age-related macular degeneration
- Stem Cell Therapy for Retinal Degeneration: The Evidence to Date
Interaction Between Mesenchymal Stem Cells and Retinal Degenerative Microenvironment
Study Highlights: Interaction Between Mesenchymal Stem Cells and Retinal Degenerative Microenvironment
Authors: Yu Lin, Xiang Ren, Yongjiang Chen, Danian Chen
Affiliations: West China Hospital, Sichuan University, China; University of Waterloo, Canada
Key Points:
Background on Retinal Degenerative Diseases (RDDs):
- RDDs, such as age-related macular degeneration (AMD), retinitis pigmentosa (RP), and diabetic retinopathy (DR), cause irreversible vision loss.
- Traditional treatments like gene therapy, neuroprotection, and anti-VEGF have limitations, especially in advanced stages.
Mesenchymal Stem Cells (MSCs):
- MSCs are promising due to their neurotrophic, immunomodulatory capabilities, and low tumor formation risk.
- They can be sourced from various tissues including bone marrow, adipose tissue, and umbilical cord.
Pre-Clinical and Clinical Studies:
- Pre-clinical studies show MSCs can delay retinal degeneration.
- Clinical trials indicate MSCs’ safety
Mechanisms of MSCs:
- Paracrine Activity: MSCs secrete growth factors, cytokines, and extracellular vesicles that promote retinal cell survival.
- Tunneling Nanotubes (TNTs): MSCs can transfer mitochondria to retinal cells, enhancing their function.
- Immunomodulation: MSCs release anti-inflammatory cytokines, reducing retinal inflammation.
Therapeutic Potential and Safety:
- MSCs show potential in preserving and restoring vision in advanced RDD stages.
- Challenges include ensuring safety, efficacy, and avoiding immune rejection.
Current Research and Future Directions:
- Research focuses on understanding MSCs’ interactions with the retinal environment.
- Addressing MSC product heterogeneity and optimizing delivery methods are crucial for successful treatments.
Summary:
Retinal degenerative diseases (RDDs) lead to vision loss, with limited treatment options available. Mesenchymal stem cells (MSCs) offer a promising therapeutic approach due to their ability to support retinal cell survival and modulate the immune response. Pre-clinical studies have shown MSCs can delay degeneration, and clinical trials have indicated promising safety profiles.
MSCs interact with the retinal environment primarily through paracrine activity, TNTs, and immunomodulation. They secrete growth factors and cytokines, transfer mitochondria to retinal cells, and reduce inflammation, promoting retinal cell survival and function.
While MSCs hold great potential for treating RDDs, challenges remain, including ensuring product consistency, optimizing delivery methods, and avoiding immune rejection. Ongoing research aims to better understand MSC interactions with the retinal environment to enhance their therapeutic efficacy and safety.
This study emphasizes the need for rigorous research and clinical practices to maximize the benefits of MSC therapies for retinal degenerative diseases.
Macular Degeneration Stem Cell Treatment Potential Side Effects & Risks
Potential Side Effects & Risks
- Swelling or inflammation at the injection site. This is unlikely to occur because the stem cells are injected below the eye.
- Swelling or inflammation if a blood vessel is ruptured. The doctor aspirates the needle to ensure he is not in a blood vessel and there are very few in this area.
- Injection Site Infections: The injection procedure can introduce infections, leading to serious complications if not properly managed. We sterilize everything and each patient is given an analysis of their stem cells to prove they are bacteria and endotoxin free as seen here – Certified Stem Cells
- Increased Intraocular Pressure: MSC treatments can cause secondary glaucoma due to increased intraocular pressure, potentially damaging the optic nerve.
- Vision Loss: This has not occurred with any of our patients, but any eye treatment runs this risk.
- No Effect or Results from Treatment: This is a medical treatment and success cannot be guaranteed. We have a very high success rate, but there are always patients that are non-responders to this treatment.
How Long do Macular Degeneration Stem Cell Treatment
The results from the macular degeneration stem cell treatment can last for years or even indefinitely. This is because the stem cells are guiding the cellular repair and regeneration of the eye. This will last because it is real regeneration and not just a pill to cover up symptoms.
The mesenchymal stem cells that are administered will stay in the system for 8 months to a year. During that time they will interact with immune cells and seek out inflammation where they will guide cellular regeneration. After 8 to 12 months any MSCs that are free bound in your system will differentiate into an osteoblast (bone cell), adipocyte (fat cell) or chondrocyte (cartilage cell). They will then contain the donors HLA markers and your immune system will destroy and remove them. This is an easy process for your immune system and there is no negative reaction in your body from it. Some of the MSCs that were free bound from the IV will find capillaries to call home. They will attach and be considered a pericyte. When they do this they can live in your system indefinitely in a beneficial way to your system.
The Macular Degeneration Stem Cell Treatment is allowing your body to heal like it did when you were a little kid.
